Juan Pablo Escalera-Antezana1, Omar J Rodriguez-Villena2, Ariel Weimar Arancibia-Alba3, Lucia Elena Alvarado-Arnez1, D Katterine Bonilla-Aldana4, Alfonso J Rodríguez-Morales5. 1. Universidad Franz Tamayo/UNIFRANZ, Cochabamba, Bolivia. 2. Emergency Department and Emergency Medical Residency Program Coordination, Hospital Obrero N1, Caja Nacional de Salud, La Paz, Bolivia. 3. Chief Executive, Departmental Health Services (SEDES), La Paz, Bolivia. 4. Incubator in Zoonosis (SIZOO), Biodiversity and Ecosystem Conservation Research Group (BIOECOS), Fundación Universitaria Autónoma de las Américas, Sede Pereira, Pereira, Risaralda, Colombia; Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia. 5. Universidad Franz Tamayo/UNIFRANZ, Cochabamba, Bolivia; Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia. Electronic address: arodriguezm@utp.edu.co.
Abstract
INTRODUCTION: In 2003 an emerging mammarenavirus (formerly arenaviruses) was discovered in Bolivia and named Chapare (CHAPV). It was associated with severe and fatal hemorrhagic fever, being similar in clinical features to Machupo (MACV). In mid-2019, CHAPV was the cause of a cluster of five cases, two of them laboratory confirmed, three of them fatal. Here, we report the main clinical findings, epidemiological features and the potential ecological aspects, of that cluster of cases in rural La Paz, Bolivia. METHODS: For this observational, retrospective and cross-sectional study, information was obtained from the Hospitals and the Ministry of Health for the cases that were laboratory-diagnosed and related, during 2019. RT-PCR was used for the detection of the RNA of CHAPV in the blood samples. RESULTS: Two cases were RT-PCR + for CHAPV. The median age of patients was 42 y-old (IQR 25-45), four out of five were male. All patients were hospitalized, admitted to the ICU and had fever, upper digestive hemorrhage, with two of them, presenting ARDS, and requiring mechanical ventilation. Three patients died (case fatality rate, CFR 60%). CONCLUSIONS: Mammarenaviruses led to a high fatality rate. These cases occurred in areas with suitable ecoepidemiological conditions for rodent-borne diseases, including CHAPV infection. Socioenvironmental and occupational factors in rural areas of Bolivia may contribute with the risk of zoonotic spillover and transmission to humans.
INTRODUCTION: In 2003 an emerging mammarenavirus (formerly arenaviruses) was discovered in Bolivia and named Chapare (CHAPV). It was associated with severe and fatal hemorrhagic fever, being similar in clinical features to Machupo (MACV). In mid-2019, CHAPV was the cause of a cluster of five cases, two of them laboratory confirmed, three of them fatal. Here, we report the main clinical findings, epidemiological features and the potential ecological aspects, of that cluster of cases in rural La Paz, Bolivia. METHODS: For this observational, retrospective and cross-sectional study, information was obtained from the Hospitals and the Ministry of Health for the cases that were laboratory-diagnosed and related, during 2019. RT-PCR was used for the detection of the RNA of CHAPV in the blood samples. RESULTS: Two cases were RT-PCR + for CHAPV. The median age of patients was 42 y-old (IQR 25-45), four out of five were male. All patients were hospitalized, admitted to the ICU and had fever, upper digestive hemorrhage, with two of them, presenting ARDS, and requiring mechanical ventilation. Three patients died (case fatality rate, CFR 60%). CONCLUSIONS: Mammarenaviruses led to a high fatality rate. These cases occurred in areas with suitable ecoepidemiological conditions for rodent-borne diseases, including CHAPV infection. Socioenvironmental and occupational factors in rural areas of Bolivia may contribute with the risk of zoonotic spillover and transmission to humans.
Authors: D Katterine Bonilla-Aldana; Yeimer Holguin-Rivera; Soffia Perez-Vargas; Adrian E Trejos-Mendoza; Graciela J Balbin-Ramon; Kuldeep Dhama; Paola Barato; Charlene Lujan-Vega; Alfonso J Rodriguez-Morales Journal: One Health Date: 2020-06-25
Authors: Fernanda de Mello Malta; Deyvid Amgarten; Ana Catharina de Seixas Santos Nastri; Yeh-Li Ho; Luciana Vilas Boas Casadio; Marcela Basqueira; Gloria Selegatto; Murilo Castro Cervato; Amaro Nunes Duarte-Neto; Hermes Ryoiti Higashino; Felipe Arthur Faustino Medeiros; José Luiz Pinto Lima Gendler; Anna S Levin; João Renato Rebello Pinho Journal: Emerg Infect Dis Date: 2020-06 Impact factor: 6.883
Authors: Shawn Herring; Jessica M Oda; Jessica Wagoner; Delaney Kirchmeier; Aidan O'Connor; Elizabeth A Nelson; Qinfeng Huang; Yuying Liang; Lisa Evans DeWald; Lisa M Johansen; Pamela J Glass; Gene G Olinger; Aleksandr Ianevski; Tero Aittokallio; Mary F Paine; Susan L Fink; Judith M White; Stephen J Polyak Journal: Antimicrob Agents Chemother Date: 2021-03-18 Impact factor: 5.191
Authors: Alfonso J Rodríguez-Morales; D Katterine Bonilla-Aldana; Alejandro Risquez; Alberto Paniz-Mondolfi; José Antonio Suárez Journal: New Microbes New Infect Date: 2021-11-11
Authors: Brian B Gowen; Shibani Naik; Jonna B Westover; Eric R Brown; Vidyasagar R Gantla; Alexandra Fetsko; Ashley L Dagley; Dallan J Blotter; Nicole Anderson; Ken McCormack; Greg Henkel Journal: Antiviral Res Date: 2021-06-29 Impact factor: 10.103
Authors: Yu-Jin Kim; Beatrice Cubitt; Yingyun Cai; Jens H Kuhn; Daniel Vitt; Hella Kohlhof; Juan C de la Torre Journal: Viruses Date: 2020-07-29 Impact factor: 5.048
Authors: Juan Pablo Escalera-Antezana; Nicolas Freddy Lizon-Ferrufino; Americo Maldonado-Alanoca; Gricel Alarcón-De-la-Vega; Lucia Elena Alvarado-Arnez; María Alejandra Balderrama-Saavedra; D Katterine Bonilla-Aldana; Alfonso J Rodríguez-Morales Journal: Travel Med Infect Dis Date: 2020-04-02 Impact factor: 6.211